K
Kimihiro Komori
Researcher at Nagoya University
Publications - 219
Citations - 5176
Kimihiro Komori is an academic researcher from Nagoya University. The author has contributed to research in topics: Abdominal aortic aneurysm & Endovascular aneurysm repair. The author has an hindex of 32, co-authored 207 publications receiving 4170 citations. Previous affiliations of Kimihiro Komori include Kyushu University.
Papers
More filters
Journal ArticleDOI
Global vascular guidelines on the management of chronic limb-threatening ischemia
Michael S. Conte,Andrew W. Bradbury,Philippe Kolh,John V. White,Florian Dick,Robert Fitridge,Joseph L. Mills,Jean-Baptiste Ricco,Kalkunte R Suresh,M. Hassan Murad,Victor Aboyans,Murat Aksoy,Vlad-Adrian Alexandrescu,David G. Armstrong,Nobuyoshi Azuma,Jill J. F. Belch,Michel Bergoeing,Martin Björck,Nabil Chakfe,Stephen W.K. Cheng,Joseph Dawson,Eike Sebastian Debus,Andrew Dueck,Sue Duval,Hans-Henning Eckstein,Roberto Ferraresi,Raghvinder Gambhir,Mauro Gargiulo,Patrick J. Geraghty,Steve Goode,Bruce H. Gray,Wei Guo,Prem C. Gupta,Robert J. Hinchliffe,Prasad Jetty,Kimihiro Komori,Lawrence A. Lavery,Wei Liang,Robert A. Lookstein,Matthew T. Menard,Sanjay Misra,Tetsuro Miyata,Greg Moneta,Jose A. Munoa Prado,Alberto Munoz,Juan E. Paolini,Manesh R. Patel,Frank B. Pomposelli,Richard J. Powell,Peter A Robless,Lee C. Rogers,Andres Schanzer,Peter Schneider,Spence M. Taylor,Melina Vega de Ceniga,Martin Veller,Frank Vermassen,Jinsong Wang,Shenming Wang +58 more
TL;DR: The GVG proposes a new Global Anatomic Staging System (GLASS), which involves defining a preferred target artery path (TAP) and then estimating limb-based patency (LBP) resulting in three stages of complexity for intervention.
Journal ArticleDOI
Angiogenic gene therapy for experimental critical limb ischemia: Acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2
Ichiro Masaki,Yoshikazu Yonemitsu,Akihisa Yamashita,Shihoko Sata,Mitsugu Tanii,Kimihiro Komori,Kazunori Nakagawa,Xiaogang Hou,Yoshiyuki Nagai,Mamoru Hasegawa,Keizo Sugimachi,Katsuo Sueishi +11 more
TL;DR: VEGF is necessary, but should be delicately regulated to lower expression to treat ischemic limb, and the therapeutic effect of FGF-2, associated with the harmonized angiogenic effects seen with endogenous VEGF, provides important insights into therapeutic angiogenesis.
Journal ArticleDOI
Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.
Masahiro Kajiguchi,Takahisa Kondo,Hideo Izawa,Masayoshi Kobayashi,Koji Yamamoto,Satoshi Shintani,Yasushi Numaguchi,Tomoki Naoe,Junki Takamatsu,Kimihiro Komori,Toyoaki Murohara +10 more
TL;DR: The TACT regimen improved CLI in patients with Buerger's disease but not in those with ASO-HD in this small study.
Journal ArticleDOI
Electrical responses of smooth muscle cells during cholinergic vasodilation in the rabbit saphenous artery.
Kimihiro Komori,H Suzuki +1 more
TL;DR: The results suggest that the inhibitory actions of muscarinic agonists on electrical responses of smooth muscle cells of the rabbit saphenous artery were mainly indirect, i.e., a release of inhibitory substances from the endothelial cells and the inhibition of adrenerglc transmission.
Journal ArticleDOI
Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits.
E. Mori,Kimihiro Komori,Terutoshi Yamaoka,Mitsugu Tanii,Chu Kataoka,Akira Takeshita,Makoto Usui,Kensuke Egashira,Keizo Sugimachi +8 more
TL;DR: MCP-1–mediated monocyte infiltration is necessary in the development of restenotic changes to balloon injury in hypercholesterolemic rabbits and this strategy may be a useful and practical form of gene therapy against human restenosis.